Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of 1.10 trillion as of March 9, 2026. Its market cap has decreased by -57.73% in one year.

Market Cap

1.10T

Enterprise Value

1.21T

Revenue

309.06B

Ranking

n/a

PE Ratio

10.76

Stock Price

254.50

Market Cap Chart

Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.10T, an increase of 2,294.58%. That is a compound annual growth rate of 11.55%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	1,101.56B	-23.78%
Dec 30, 2025	1,445.24B	-47.87%
Dec 30, 2024	2,772.28B	-10.93%
Dec 29, 2023	3,112.33B	46.89%
Dec 30, 2022	2,118.80B	26.50%
Dec 30, 2021	1,674.99B	69.77%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Genmab	106.28B
Coloplast	103.91B
ALK-Abelló	49.32B
Demant	39.54B
H. Lundbeck	36.71B
Ambu A/S	20.05B
Zealand Pharma	16.59B
Bavarian Nordic	14.16B

Market Cap Rankings